Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review

October 2021 | 42 pages | ID: PE9EE5133F9EN
GlobalData

Abstracts

Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pharmaniaga Berhad (Pharmaniaga), a member of Boustead Group is an investment holding company. It is an integrated pharmaceutical group that operates across a wide spectrum of the healthcare industry through its subsidiaries. The company carries out logistics and distribution and manufacturing of generic pharmaceuticals; and sales, marketing, and distribution of medical products and hospital equipment. Pharmaniaga also operates community pharmacies in Malaysia; and provides pharmaceutical products, diagnostic products and food supplements in Indonesia. The company has manufacturing facilities and logistics and distribution warehouses in Malaysia and Indonesia; and operates across Malaysia, Indonesia. Pharmaniaga is headquartered at Shah Alam, Selangor, Malaysia.

Pharmaniaga Berhad Key Recent Developments

Aug 20,2021: Pharmaniaga Announces Financial Results for the year ended June 30, 2021
Aug 20,2021: Pharmaniaga Announces Change in Board
May 21,2021: Pharmaniaga announces quarterly report on consolidated results for the financial period ended 31 March 2021
May 21,2021: Pharmaniaga Announces Notice of Twenty-Third Annual General Meeting
Mar 17,2021: Pharmaniaga Announces Interim Dividend

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Pharmaniaga Berhad - Key Facts
Pharmaniaga Berhad - Key Employees
Pharmaniaga Berhad - Key Employee Biographies
Pharmaniaga Berhad - Major Products and Services
Pharmaniaga Berhad - History
Pharmaniaga Berhad - Company Statement
Pharmaniaga Berhad - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Pharmaniaga Berhad - Business Description
Business Segment: Indonesia
Overview
Performance
Business Segment: Logistics and Distribution
Overview
Performance
Business Segment: Manufacturing
Overview
Performance
Geographical Segment: Indonesia
Performance
Geographical Segment: Malaysia
Performance
Geographical Segment: Other Countries
Performance
Pharmaniaga Berhad - SWOT Analysis
SWOT Analysis - Overview
Pharmaniaga Berhad - Strengths
Pharmaniaga Berhad - Weaknesses
Pharmaniaga Berhad - Opportunities
Pharmaniaga Berhad - Threats
Pharmaniaga Berhad - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Pharmaniaga Berhad, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 20, 2021: Pharmaniaga Announces Financial Results for the year ended June 30, 2021
Aug 20, 2021: Pharmaniaga Announces Change in Board
May 21, 2021: Pharmaniaga announces quarterly report on consolidated results for the financial period ended 31 March 2021
May 21, 2021: Pharmaniaga Announces Notice of Twenty-Third Annual General Meeting
Mar 14, 2021: Pharmaniaga announce Quarterly report on consolidated results for the financial period ended 31/12/2020
Mar 01, 2021: Pharmaniaga Announces Resignation of Independent and Non Executive Chairman

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Pharmaniaga Berhad, Key Facts
Pharmaniaga Berhad, Key Employees
Pharmaniaga Berhad, Key Employee Biographies
Pharmaniaga Berhad, Major Products and Services
Pharmaniaga Berhad, History
Pharmaniaga Berhad, Subsidiaries
Pharmaniaga Berhad, Key Competitors
Pharmaniaga Berhad, Ratios based on current share price
Pharmaniaga Berhad, Annual Ratios
Pharmaniaga Berhad, Annual Ratios (Cont...1)
Pharmaniaga Berhad, Annual Ratios (Cont...2)
Pharmaniaga Berhad, Interim Ratios
Pharmaniaga Berhad, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Pharmaniaga Berhad, Performance Chart (2016 - 2020)
Pharmaniaga Berhad, Ratio Charts